METHOD FOR STIMULATING VISION FUNCTION IN LENS SUBLUXATION CASES ACCOMPANIED WITH CONNECTIVE TISSUE SYSTEM METABOLISM DISORDERS Russian patent published in 2007 - IPC A61F9/00 A61F9/08 A61K31/573 A61K31/44 A61K31/714 A61K31/525 A61K36/16 A61N5/67 A61K31/205 A61K31/51 A61N2/04 A61K31/196 A61K31/4415 A61P27/02 

FIELD: medicine.

SUBSTANCE: method involves carrying out lensectomy. Retrobulbar catheterization is next applied using irrigation system to introduce Dexazon, Riboflavin, Dicinon, Actipol, Emoxipin at a dose of 0.4 ml during 10 days. The preparations are introduced fractionally in arbitrary sequence with 2 h long pauses. Laserpleoptic treatment with SPECLE apparatus operating at wavelength of 0.63 mcm and sequential magnetic treatment of four zones on head, that is, frontal, temporal, parietal auriculo-temporal and occipital ones. Optic nerve light stimulation is concurrently carried out using Medopotica MS-11 apparatus operating at pulsation frequency growing from 20 to 50 Hz in narrow spectral zone of 660 nm and magnetic field intensity of 300 mTesla units during 5 min one session per day during 10 days. Ginkgo biloba preparations and MILGAMMA in capsules are administered in age-specific doses as outpatient procedure during 1 month, after having finished stationary treatment course.

EFFECT: improved vision functions; improved connective tissue trophism.